Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer- A Budget Impact Analysis

May 1, 2013, 00:00
10.1016/j.jval.2013.03.638
https://www.valueinhealthjournal.com/article/S1098-3015(13)00709-2/fulltext
Title : Egfr Test-Guided Erlotinib Versus Chemotherapy For First-Line Treatment Of Advanced Non-Small Cell Lung Cancer- A Budget Impact Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00709-2&doi=10.1016/j.jval.2013.03.638
First page : A131
Section Title : Cancer
Open access? : No
Section Order : 188
Categories :
Tags :
Regions :
ViH Article Tags :